Medical Technology Group
The Medical Technology Group (MTG) was launched in 2000 to lobby for medical technologies in the NHS.
MTG describes itself as "a coalition of patient groups, research charities and medical device manufacturers working to improve access to medical technologies for everyone who needs them. Medical technology gives value for money to the NHS, patients and taxpayers but uptake of medical technologies in the UK is not as good as it should be. MTG is interested in a variety of clinical areas but has a common objective in securing patient access to the best diagnostic, imaging, surgical and supported living technology".[1]
MTG members
AdvaMed, Abbot Medical Optics, AntiCoagulation Europe, ARMA, Arrhythmia Alliance, Arthritis Care, Atrial Fibrillation Association, Association of British Healthcare Industries, BD, Bladder and Bowel Foundation, Boston Scientific, British Cardiac Patients’ Association, Cardiomyopathy Association, Circulation Foundation, ConvaTec, CR Bard, Dexcom, Eucomed, FABLE, FEmISA, Heart Research UK, ICD Group, Inappropriate Sinus Tachycardia Info and Support, International Alliance of Patients’ Organizations, INPUT, Johnson & Johnson, The Juvenile Diabetes Research Foundation, The Lindsay Leg Club Foundation, Medtronic, National Rheumatoid Arthritis Society, The Patients Association, Patient Information Forum, Pelvic Pain Support Network, Roche Diagnostics, SADS UK, St Jude Medical, STARS, Stryker, Transplant Support Network, Zimmer[2]
It also includes the following trade associations (in 2010): Association of British Healthcare Industries, AdvaMed, Eucomed as well as individual medical technology companies.[3]
What the MTG wants
The MTG believes that: 1. Medical Technology gives value for money to the NHS, patients and taxpayers.
2. Uptake of medical technology in the UK is not as good as it should be.
3. People need more information about medical technologies to help unlock their value. [4]
It therefore wants:
- More information for patients on what technologies are available and appropriate for them, to enable shared decision‐making.
- Training/guidance for clinicians on the choices of medical technology available and how to use them.
- Dissemination of guidance and best practice (location of centres of excellence) that explains the patient and cost benefits of appropriate use of medical technology to those commissioning services (i.e medical technology interventions included within NICE quality standards).
- Involvement of patients in commissioning decisions/oversight.
- Top‐down systems that incentivise quality and cost effectiveness rather than short-term cost reduction. [5]
Contacts
MTG lists its PR and lobbying company Weber Shandwick as the Group's secretariat and contact point.
- Care of /Weber Shandwick
- Fox Court
- 14 Gray’s Inn Road
- London, WC1X 8WS
Use this mail, mail@mtg.org.uk, if you want to contact the MTG secretariat. [6]
References
- ↑ MTG website MEDICAL TECHNOLOGY AND INNOVATION, accessed Feb 2011
- ↑ MTG website Members, accessed Feb 2011
- ↑ MTG website Members, accessed Nov 2010
- ↑ Achieving QIPP through improved use of technology in the NHS [1], accessed Feb 2011
- ↑ Achieving QIPP through improved use of technology in the NHS, accessed Feb 2011
- ↑ MTG website MEDICAL TECHNOLOGY AND INNOVATION, accessed Feb 2011
